Gynecology

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study revealed that allogeneic hematopoietic stem cell transplantation does not lead to disease relapse in patients with acute leukemia undergoing ovarian tissue transplantation.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent exposed the relationship between financial strain, underutilization of health care, and comorbidities, shedding light on the heightened risks.

A recent study revealed that physician awareness of patients' desired level of decision-making significantly enhances satisfaction, highlighting the importance of tailored approaches for women with pelvic floor disorders seeking patient-centered care.

The digital editor for Contemporary OB/GYN offers his thoughts on trends and news in women’s health this past year.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study unveiled a novel screening method, utilizing validated questionnaires to accurately identify myofascial urinary frequency syndrome in patients with lower urinary tract symptoms.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study reveals that relugolix combination therapy demonstrates sustained reduction in menstrual bleeding volume for women with symptomatic uterine fibroids.

A recent study reveals heightened rates of concomitant bilateral salpingo-oophorectomy during benign hysterectomy in women with disabilities, shedding light on potential disparities and urging improved physician counseling and shared decision-making strategies.

Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, outlines treatment options for uterine fibroids in patients with different needs.

Jay Goldberg, MD, ob-gyn at Einstein Medical Center of Philadelphia, discusses treatment paradigms which can help clinicians manage abnormal uterine bleeding in their patients.

Daré Bioscience's tamoxifen-based therapy, DARE-VVA1, secures FDA clearance for an investigational new drug application, offering hope for women with contraindications to estrogen therapies suffering from the underdiagnosed condition of vulvar and vaginal atrophy.

Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.

A recent study in Microorganisms reveals that Metronidazole treatment failure in bacterial vaginosis is linked to elevated activated T- and dendritic-cell subsets, potentially heightening susceptibility to HIV.

Kirstin E. Leitner, MD, assistant professor of clinical obstetrics and gynecology at Penn Medicine, discusses how the artificial intelligence program "Penny" can be used to improve care in obstetrics and gynecology.

A recent study indicates that early use of intrauterine balloon tamponade does not significantly reduce severe postpartum hemorrhage risk compared to its application after second-line uterotonic treatment failure.

In a recent study, patients who were treated for heavy menstrual bleeding with the levonorgestrel intrauterine system had similar changes in bleeding-related quality of life as those using combined oral contraceptives for treatment.

A recent study unveils the diagnostic potential of the Convergences pelvic pain (PP) score for identifying central sensitization in women with chronic pelvic pain.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

The pivot to patient safety.

Findings and significance for gynecologic surgeons.

Learn how obstetrician-gynecologists can use artificial intelligence to improve their practice.

In a recent study, vaginal laxity symptoms were significantly improved in patients receiving electroporation therapy vs placebo.